Platelet-derived TLT-1 promotes tumor progression by suppressing CD8+ T cells is a research paper published in The Journal of Experimental Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 42 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart, Lung, and Blood Institute
Grant: RO1-HL122815
National Heart, Lung, and Blood Institute
Grant: RO1-HL115247
National Heart, Lung, and Blood Institute
Grant: RO1-HL150515
NCATS NIH HHS
Grant: UL1 TR001863
NHLBI NIH HHS
Grant: R01 HL115247
NHLBI NIH HHS
Grant: R01 HL122815
NHLBI NIH HHS
Grant: R01 HL150515
FWCI
3.35
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Interactions of platelets with obesity in relation to lung cancer risk in the UK Biobank cohort
Additional file 1 of Interactions of platelets with obesity in relation to lung cancer risk in the UK Biobank cohort